ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 121 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $42,604 | -57.3% | 12,138 | -18.7% | 0.00% | -100.0% |
Q3 2023 | $99,752 | +74.5% | 14,933 | +159.4% | 0.00% | – |
Q1 2023 | $57,167 | -90.8% | 5,757 | -95.0% | 0.00% | -100.0% |
Q3 2022 | $621,000 | +68.8% | 116,285 | +26.0% | 0.00% | +50.0% |
Q2 2022 | $368,000 | +493.5% | 92,297 | +560.0% | 0.00% | +100.0% |
Q1 2022 | $62,000 | -81.6% | 13,985 | -83.4% | 0.00% | -66.7% |
Q4 2021 | $337,000 | -11.3% | 84,342 | +95.0% | 0.00% | -40.0% |
Q3 2021 | $380,000 | -72.2% | 43,252 | -64.2% | 0.01% | -66.7% |
Q2 2021 | $1,369,000 | +38.7% | 120,849 | +45.4% | 0.02% | +15.4% |
Q1 2021 | $987,000 | +494.6% | 83,117 | +242.7% | 0.01% | +550.0% |
Q4 2020 | $166,000 | +1744.4% | 24,257 | +2000.2% | 0.00% | – |
Q3 2020 | $9,000 | -89.8% | 1,155 | -92.4% | 0.00% | -100.0% |
Q4 2019 | $88,000 | +193.3% | 15,150 | +198.7% | 0.00% | +100.0% |
Q2 2019 | $30,000 | – | 5,072 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |